These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9854581)

  • 1. Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size.
    Lowney JK; Frisella MM; Lairmore TC; Doherty GM
    Surgery; 1998 Dec; 124(6):1043-8, discussion 1048-9. PubMed ID: 9854581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1.
    Selberherr A; Koperek O; Riss P; Scheuba C; Niederle MB; Kaderli R; Perren A; Niederle B
    Orphanet J Rare Dis; 2019 Feb; 14(1):54. PubMed ID: 30795813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
    Lairmore TC; Chen VY; DeBenedetti MK; Gillanders WE; Norton JA; Doherty GM
    Ann Surg; 2000 Jun; 231(6):909-18. PubMed ID: 10816635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.
    Long KB; Srivastava A; Hirsch MS; Hornick JL
    Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
    Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
    Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study.
    Weber HC; Venzon DJ; Lin JT; Fishbein VA; Orbuch M; Strader DB; Gibril F; Metz DC; Fraker DL; Norton JA
    Gastroenterology; 1995 Jun; 108(6):1637-49. PubMed ID: 7768367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of surgery in management of adrenocorticotropic hormone-producing islet cell tumors of the pancreas.
    Amikura K; Alexander HR; Norton JA; Doppman JL; Jensen RT; Nieman L; Cutler G; Chrousos G; Fraker DL
    Surgery; 1995 Dec; 118(6):1125-30. PubMed ID: 7491532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1.
    MacFarlane MP; Fraker DL; Alexander HR; Norton JA; Lubensky I; Jensen RT
    Surgery; 1995 Dec; 118(6):973-9; discussion 979-80. PubMed ID: 7491542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large and asymptomatic pancreatic islet cell tumor in a patient with multiple endocrine neoplasia type 1.
    Sato M; Kihara M; Nishitani A; Murao K; Kobayashi S; Miyauchi A; Takahara J
    Endocrine; 2000 Dec; 13(3):263-6. PubMed ID: 11216636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area.
    Madeira I; Terris B; Voss M; Denys A; Sauvanet A; Flejou JF; Vilgrain V; Belghiti J; Bernades P; Ruszniewski P
    Gut; 1998 Sep; 43(3):422-7. PubMed ID: 9863490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
    Guo SS; Wu AY; Sawicki MP
    World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pathology of insulinoma and gastrinoma. The location, size, multicentricity, association with multiple endocrine type-I neoplasms and malignancy].
    Donow C; Pipeleers-Marichal M; Stamm B; Heitz PU; Klöppel G
    Dtsch Med Wochenschr; 1990 Sep; 115(37):1386-91. PubMed ID: 1976084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine pancreatic tumors: factors correlated with survival.
    Tomassetti P; Campana D; Piscitelli L; Casadei R; Santini D; Nori F; Morselli-Labate AM; Pezzilli R; Corinaldesi R
    Ann Oncol; 2005 Nov; 16(11):1806-10. PubMed ID: 16085691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2001 Oct; 234(4):495-505; discussion 505-6. PubMed ID: 11573043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of a complex endocrinopathy.
    Cooney T; Benediktsson H; Mukai K
    Am J Surg Pathol; 1980 Oct; 4(5):491-9. PubMed ID: 6254381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1.
    Mutch MG; Frisella MM; DeBenedetti MK; Doherty GM; Norton JA; Wells SA; Lairmore TC
    Surgery; 1997 Dec; 122(6):1012-9; discussion 1019-20. PubMed ID: 9426414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathologic study with immunohistochemistry of 61 pancreatic endocrine tumors in 16 patients suffering from multiple endocrine neoplasia type I (MEN I). Review of the literature].
    Heymann MF; Moreau A; Chetritt J; Murat A; Leborgne J; Le Neel JC; Visset J; Le Bodic MF
    Ann Pathol; 1996; 16(3):167-73. PubMed ID: 8766173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
    Anlauf M; Schlenger R; Perren A; Bauersfeld J; Koch CA; Dralle H; Raffel A; Knoefel WT; Weihe E; Ruszniewski P; Couvelard A; Komminoth P; Heitz PU; Klöppel G
    Am J Surg Pathol; 2006 May; 30(5):560-74. PubMed ID: 16699310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of pancreatic neuroendocrine tumors.
    Metz DC
    Semin Gastrointest Dis; 1995 Apr; 6(2):67-78. PubMed ID: 7788285
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.